Offering

Medicines

At the center of our portfolio stand medicines designed to treat type 2 diabetes and complications accompanying this disease. We also offer medicines for the treatment of opioid-induced constipation, breakthrough pain and the treatment and prophylaxis of thromboembolic disease.

Novapio

pioglitazone

Drug from the group of thiazolidinediones, oral antidiabetic, treatment of type 2 diabetes mellitus, treatment of hyperglycemia, in the form of tablets.

Repaglinide Accord

repaglinide

Medicine from the glinides group, oral antidiabetic, treatment of type 2 diabetes mellitus, treatment of postprandial glycemia, in the form of tablets.

Zaxivia

sitagliptin

A medicinal product from the group of DPP4 inhibitors containing sitagliptin, an oral antidiabetic drug, treatment of type 2 diabetes mellitus, in tablet form.

Zaxoran

Fixed combination of sitagliptin and metformin, oral antidiabetic drug, treatment of type 2 diabetes mellitus, in tablet form

Zexitor

Metformin extended release

Extended release tablet, oral antidiabetic, treatment of Type 2 Diabetus Mellitus, treatment of hyperglycaemia, in tablet form.

Publicly accessible information line (PAPIS)

The obligation to establish a Publicly Accessible Professional Information Service (PAPIS) result from Act No. 378/2007 Sb., O léčivech. Information on our products can be found on the website of the State Institute for Drug Control (SÚKL) in the drug database. Summaries of Product Characteristics can be found in the pdf. file by clicking on the Product name.